Macroaxis: Personalized Investing
Personalized Investing and
Digital Wealth Optimization

GILD AMGN BIIB CELG Large Growth Entertainment Music and Video 
Benchmark  United States  NYSE  10,533   27.041 Index Moved Up 0.26%  

Collecting data for STEM

StemCells Inc

 Companies |  Insiders  | Dashboard  
Year To Date
Last 1 Month(s)
Trading Day 
5 Days Price Trend
April 20 2014 
Highest Price  
Lowest Price  
March 21 2014 
April 15 2014 

StemCells Market Sensitivity

As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, StemCells will likely underperform.
StemCells Inc Large BetaStemCells Inc Beta Legend
StemCells Inc
USA Stock
Benchmark NYSE
Contact Number: 510. 456. 4000
Currency: USD - US Dollar
Traded on Nasdaq Capital Markets
Current Valuation53.99 M
Shares Outstanding55.42 M
Number of Shares Shorted1.6 M
Revenue1.2 M
 thisGreen STEM STEM agains markets  1.63 % Macroaxis: change 1.63 Moved Up  
 United States Russel   0.54 % Macroaxis: 0.54 Moved Up  
 United States NYSE   0.26 % Macroaxis: 0.26 Moved Up  
 United States Nasdaq   0.23 % Macroaxis: 0.23 Moved Up  
 United States SP 500   0.14 % Macroaxis: 0.14 Moved Up  
Compare to Competition Alpha & Beta   Get Advice

StemCells Leadership

Martin McGlynn CEO and President Director, Member of Strategic Transactions Committee, CEO of StemCells California Inc and President of StemCells California Inc
John Schwartz Independent Chairman of the Board, Ph.D
Eliseo Salinas Executive Vice President Head - Research and Development
Gregory Schiffman CFO, Executive Vice President - Finance, MBA

StemCells Diversification Suggestion

Use StemCells to enhance returns of your portfolios. The stock experiences large bullish trend. Check odds of StemCells to be traded at $1.375 in 30 days

StemCells Price and Market Media

The median price of StemCells for the period between Fri, Mar 21, 2014 and Sun, Apr 20, 2014 is 1.31 with a coefficient of variation of 5.95. The daily time series for the period is distributed with a sample standard deviation of 0.08, arithmetic mean of 1.32, and mean deviation of 0.06. The Stock received substential amount of media coverage during this period.
StemCells Value
Change Benchmark  Embed  Timeline 

StemCells Summary

StemCells Inc [STEM] is traded on Nasdaq Capital Markets in USA. It is located in Newark, CA and employs 58 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 71.49 M. StemCells Inc conducts business under Healthcare sector and is part of Biotechnology industry. This company has 55.42 M outstanding shares of which 1.6 M shares are at this time shorted by private and institutional investors with about 1.7 trading days to cover.
StemCells, Inc., a biopharmaceutical company, is engaged in the research, development, and commercialization of stem cell therapeutics, and related tools and technologies for stem cellbased research and drug discovery and development. more

StemCells Related Equities

 United States INCY   1.27 % Macroaxis: change 1.27 Moved Up  
 United States GILD   1.04 % Macroaxis: change 1.04 Moved Up  
 United States SGEN   0.70 % Macroaxis: 0.7 Moved Up  
 United States ALXN   0.50 % Macroaxis: 0.5 Moved Up  
 United States JAZZ   0.04 % Macroaxis: 0.04 Moved Up  
 United States AMGN   0.07 % Macroaxis: 0.07 Moved Down  
 United States CELG   0.25 % Macroaxis: 0.25 Moved Down  
 United States BIIB   0.32 % Macroaxis: 0.32 Moved Down  
 United States VRTX   0.34 % Macroaxis: 0.34 Moved Down  
 United States ILMN   0.57 % Macroaxis: 0.57 Moved Down  
 United States BMRN   0.78 % Macroaxis: 0.78 Moved Down  
 United States REGN   1.13 % Macroaxis: change 1.13 Moved Down  
Past Market
Over 30
Out Of
Chance of
Hyped Up
Follow StemCells with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker

StemCells Research Report

Generate Report  

StemCells vs. Gilead

Correlation analysis and fundamentals comparison between StemCells Inc and Gilead Sciences

Fix Your Portfolios with StemCells

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add StemCells Inc to your portfolio

StemCells Executives

CPA MBA CFO and Executive VP of Fin.
Rodney Young CFO and VP of Fin. and Admin.

StemCells Directors

Irving Weissman Director, Ph.D
Roger Perlmutter Independent Director, Ph.D
Eric Bjerkholt Independent Director
R Greer Independent Director
Ricardo Levy Independent Director
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Find Alpha
Equity Screener
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals, sectors and families
Research Equities
Insiders Screener
Find insiders across different sectors to evaluate their impact on performance and growth of their entities
Research Insiders

StemCells Management

Ann Tsukamoto Executive VP of Scientific and Strategic Alliances, Ph.D
Kenneth Stratton General Counsel

StemCells Fundamentals

Short Ratio vs Number of Shares Shorted
Total Asset vs Earnings Per Share
Short Ratio vs Revenue
Cash per Share vs Earnings Per Share

StemCells vs Competition

StemCells vs. Gilead Sciences Inc
StemCells vs. Amgen Inc
StemCells vs. Biogen Idec Inc
StemCells vs. Celgene Corporation
StemCells vs. Alexion Pharmaceuticals Inc
StemCells vs. Regeneron Pharmaceuticals Inc
StemCells vs. Illumina Inc
StemCells vs. Vertex Pharmaceuticals Incorporated
StemCells vs. BioMarin Pharmaceutical Inc
StemCells vs. Incyte Corporation
StemCells vs. Jazz Pharmaceuticals Public Limited Company
StemCells vs. Seattle Genetics Inc

StemCells April 20 2014 Opportunity Range

Downside Deviation3.38
Information Ratio(0.29)
Maximum Drawdown9.07
Value At Risk(5.07)
Potential Upside3.85
Macroaxis Daily Picks
Macroaxis daily selection of potential investment opportunities
Check Daily Picks